Additional information
| Active substance | Dulaglutide | 
|---|---|
| Water Retention | No significant effect on water retention | 
| Hepatotoxicity | Minimal to no hepatotoxicity reported | 
| Lab Test | May interfere with some blood glucose tests | 
| Also known as | Not applicable | 
| Blood pressure | Can lead to a modest reduction in blood pressure | 
| Trade name | Trulicity | 
| FORM | 4 inj. pen x 0.5 ml | 
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) | 
| Chemical name | Dulaglutide | 
| Formula | C2646H4044N704O836S18 | 
| Substance class | Glucagon-like peptide-1 (GLP-1) receptor agonist | 
| Main action | Lowers blood sugar levels by enhancing glucose-dependent insulin secretion | 
| Half-life | Approximately 5 days | 
| Dosage (medical) | Generally, 0.75 mg to 1.5 mg once weekly, subcutaneously | 
| Dosage (sports) | Not applicable | 
| Effects | Improves glycemic control in type 2 diabetes | 
| Side effects | Nausea, diarrhea, vomiting, abdominal pain, decreased appetite | 
| Use in sports | Not typically used in sports | 
| Manufacturer | Lilly | 
 PCT INTEX PHARMA
							PCT INTEX PHARMA						 Anastrozole (ARIMIDEX) Zhengzhou Pharmaceutical Co.
							Anastrozole (ARIMIDEX) Zhengzhou Pharmaceutical Co.						 Plaquenil Sanofi
							Plaquenil Sanofi						 Basic Bulking Cycle Ultima Pharmaceuticals
							Basic Bulking Cycle Ultima Pharmaceuticals						 Lipitor 20 Pfizer
							Lipitor 20 Pfizer						

 
			 
			 
			 
			
Reviews
There are no reviews yet.